Is targeted removal a suitable means for tuberculosis control in wild boar?
A Che'Amat1, J A Armenteros2, D González-Barrio2
1SaBio Instituto de Investigación en Recursos Cinegéticos IREC (CSIC-UCLM-JCCM), Ronda de Toledo s.n. 13005 Ciudad Real, Spain; Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.
Preventive Veterinary Medicine
|November 16, 2016
Summary
Targeted removal of wild boar did not reduce tuberculosis (TB) prevalence. Translocating infected animals increased prevalence on the release site, highlighting challenges in TB control in wildlife populations.
Area of Science:
- Wildlife disease ecology
- Veterinary public health
- Conservation biology
Background:
- Tuberculosis (TB) poses a significant threat to wildlife populations and can spill over to livestock and humans.
- Eurasian wild boar (Sus scrofa) are known reservoirs for Mycobacterium tuberculosis complex (MTC).
- Targeted removal strategies are being explored for wildlife disease control.
Purpose of the Study:
- To assess the efficacy of targeted removal for controlling TB in a wild boar population.
- To evaluate the impact of translocating TB-infected wild boar on disease prevalence.
- To understand infection dynamics and pressure within wild boar populations.
Main Methods:
- A 60km² study area with treatment, control, and release sites was established.
- 929 wild boar were live-captured, micro-chipped, and tested for MTC antibodies.
- Seropositive wild boar were moved to a release site; seronegative boar were returned to the treatment site.
Main Results:
- Summer seroprevalence in wild boar piglets on the treatment site decreased by 39% from 2012 to 2013, but no further reduction occurred in 2014.
- Fall-winter MTC infection prevalence showed no significant changes on treatment or control sites.
- MTC infection prevalence significantly increased on the release site, from 40% to 64%.
Conclusions:
- Targeted removal failed to reduce TB prevalence in wild boar compared to a control site.
- Translocating TB-infected wild boar led to increased prevalence on the release site.
- The study provided insights into infection pressure and consequences of relocating infected wildlife.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
726
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
726
Pulmonary Tuberculosis IV
600
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
600
Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K


